Silexion Therapeutics Corporation (SLXN)

SLXN

Good news for another company LBRA
With 65 Millions of selling cmd subsidiary.

Strong buy LBRA

SLXN

Good news for another company LBRA
With 65 Millions of selling cmd subsidiary.

Strong buy LBRA

SLXN........................................p/m

SLXN...$4.10...🥳...Still Zero Borrow...

georgie18

Member Level
Re: georgie18 post# 700473

Wednesday, October 01, 2025 12:06:42 PM

Post#
700658
of 700987
SLXN...$3.73...🥳

georgie18

Member Level
Re: georgie18 post# 101

Tuesday, September 30, 2025 9:00:15 AM

Post#
103
of 103
SLXN...$3.62...🥳...Hit $5.20 This morning... https://finviz.com/news/179435/silexion-therapeutics-announces-positive-new-human-cell-line-data-confirming-pan-kras-activity-of-sil204-demonstrating-up-to-997-inhibition-and-first-evidence-in-gastric-cancer

georgie18

Member Level
Re: georgie18 post# 699499

Thursday, September 25, 2025 8:06:57 AM

Post#
699968
of 700473
SLXN...$3.98...🥳...Off my $3.50 Alert...

georgie18

Member Level
Re: georgie18 post# 99

Monday, September 22, 2025 9:58:10 AM

Post#
100
of 100
SLXN...$3.72...🥳...Off my $3.50 Alert Zero Borrow...

georgie18

Member Level
Re: 81vette post# 699220

Saturday, September 20, 2025 8:36:00 AM

Post#
699412
of 699498
SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

SLXN...$3.73...🥳

georgie18

Member Level
Re: georgie18 post# 101

Tuesday, September 30, 2025 9:00:15 AM

Post#
103
of 103
SLXN...$3.62...🥳...Hit $5.20 This morning... https://finviz.com/news/179435/silexion-therapeutics-announces-positive-new-human-cell-line-data-confirming-pan-kras-activity-of-sil204-demonstrating-up-to-997-inhibition-and-first-evidence-in-gastric-cancer

georgie18

Member Level
Re: georgie18 post# 699499

Thursday, September 25, 2025 8:06:57 AM

Post#
699968
of 700473
SLXN...$3.98...🥳...Off my $3.50 Alert...

georgie18

Member Level
Re: georgie18 post# 99

Monday, September 22, 2025 9:58:10 AM

Post#
100
of 100
SLXN...$3.72...🥳...Off my $3.50 Alert Zero Borrow...

georgie18

Member Level
Re: 81vette post# 699220

Saturday, September 20, 2025 8:36:00 AM

Post#
699412
of 699498
SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

SLXN...$3.62...🥳...Hit $5.20 This morning... https://finviz.com/news/179435/silexion-therapeutics-announces-positive-new-human-cell-line-data-confirming-pan-kras-activity-of-sil204-demonstrating-up-to-997-inhibition-and-first-evidence-in-gastric-cancer

georgie18

Member Level
Re: georgie18 post# 699499

Thursday, September 25, 2025 8:06:57 AM

Post#
699968
of 700473
SLXN...$3.98...🥳...Off my $3.50 Alert...

georgie18

Member Level
Re: georgie18 post# 99

Monday, September 22, 2025 9:58:10 AM

Post#
100
of 100
SLXN...$3.72...🥳...Off my $3.50 Alert Zero Borrow...

georgie18

Member Level
Re: 81vette post# 699220

Saturday, September 20, 2025 8:36:00 AM

Post#
699412
of 699498
SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

..$3.44 still mouse stage offering at $4 The data showed drug distribution to the liver, peritoneum and lung with "statistically significant" tumor reduction across multiple sites after SIL204 was subcutaneously administered to a metastatic pancreatic cancer mouse model, the company said.Silexion said it expects to initiate phase 2/3 clinical trials evaluating its dual-route administration approach in H1 of 2026, with regulatory submissions planned for Q4 of this year and Q1 of 2026.

SLXN...$3.98...🥳...Off my $3.50 Alert...

georgie18

Member Level
Re: georgie18 post# 99

Monday, September 22, 2025 9:58:10 AM

Post#
100
of 100
SLXN...$3.72...🥳...Off my $3.50 Alert Zero Borrow...

georgie18

Member Level
Re: 81vette post# 699220

Saturday, September 20, 2025 8:36:00 AM

Post#
699412
of 699498
SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

SLXN...$3.72...🥳...Off my $3.50 Alert Zero Borrow...

georgie18

Member Level
Re: 81vette post# 699220

Saturday, September 20, 2025 8:36:00 AM

Post#
699412
of 699498
SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

SLXN...$3.50...🥳...https://schrts.co/txFeDDEh ...Zero Borrow...Oversold Chart...Took the dip following and offering on September 11...

$4.65 + 4% ...6m shares at $4 offering news.insiders knew ahead of time of offering that's why you always quickly get in and out and don't look back 

$5s now another entry MACD wise but on rat study don't expect much $7sresistance.
Was up to $15s then MACD flipped negative for exit premarket 

🐀rat Study

. Results confirmed that SIL204 distributed to key organs where pancreatic cancer commonly spreads, with measurable reductions in tumor burden observed across multiple sites.The ability to reach metastatic sites is particularly important given that over 80% of pancreatic cancer mortality is attributed to metastatic disease, and more than 40% of initially resectable patients experience recurrence within 12 months, predominantly as distant metastases."These findings provide additional validation for a critical component of our dual-route administration strategy - the ability of subcutaneously delivered SIL204 to reach metastatic sites throughout the body," said Mitchell Shirvan, Ph.D., Chief Scientific Officer of Silexion. "Demonstrating drug distribution to the liver, peritoneum, and lung, which represent the primary sites of metastatic pancreatic cancer spread, supports our approach of combining intratumoral delivery for primary tumors with systemic administration for disseminated disease."...

$13s let's go to $60

Cancer free 

☝️🥳☝️WOOHOOOOOOOOOOO

☝️🥳☝️

$SLXN: Good news out............... now $1.10

Adding some on this news here.


GO $SLXN

SLXN reports May 29 according to Seeking Alpha

SLXN...............................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

$SLXN: Lovinnnnnnnnn it.... now $1.29

Got realllllllllllll smart on that ENTRY earlier today


Letsssssssss goooooooooooooooooooo


GO $SLXN

$SLXN: Fantasticcccccccc........ now $1.05

Loving this run up.

Don't stop now


GO $SLXN

$SLXN: Added 25k here at $0.75



Looks like it can really rip here......... bottomed out.


GO $SLXN

SLXN...$1.32...🥳... https://www.businesswire.com/news/home/20250317119505/en/PESG-Report-Silexion-Therapeutics-Breakthrough-Data-Shows-SIL204s-impact-on-both-Primary-Tumors-Metastasis-Signaling-a-Potential-Paradigm-Shift-in-Cancer-Treatment

SLXN $1.48..$9 price target ..

SLXN $1.56.... Silexion's Groundbreaking Orthotopic Model Data and the Potential Expansion of its Development Plan Position SIL204 as Potential Transformative Therapy; Wall Street Maintains Buy Rating and  Price Target representing a signifcant premium of almost +600% over current prices; Silexion expanded development plan expected to be completed shortly; Precision Oncology M&A Market has heated up in recent years with a series of Multi-Billion Dollar Acquisitions in the field...

SLXN..................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

.

SLXN...........................................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

Data analysis is currently underway, with initial results expected to be reported in March 2025. These findings will inform Silexion's development strategy for SIL-204 in addressing both localized and metastatic pancreatic cancer.

SLXN under $2

SLXN..................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

SLXN...........................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

Dilution!! After hours dumping check it out!!

SLXN: Nice one!!! (Even though their PR today is blatant FALSE ADVERTISING!!! Verbiage that deliberately misleads readers into believing "50% reduction" in tumor sizes, and "complete necrosis" of many tumors!! In FACT, not even one Human cancer patient has tasted ANY of their nonsense!!! Only in "PRECLINICAL MODELS"!!! What a frickin' SCAM the Wall Street casino has become!!!!)

SLXN........................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

Not breaking 2.56 might be a good time to unload some.....

resistance at 2.56 then at 3.52 I missed this I loaded money into my fidelity yesterday but the funds still haven't settled was gonna get in at 1.29 this sucks.

IN Here

SLXN is a great multi-dollars opportunity!

WOOHOOOOOOOOOOOOOOOOO🤑🤑🤑🤑🤑☝️🚀

SLXN: Yes indeed, and that other one was an 'ALUR-ing' play.

SLXN: Mucho thankohs for ALL of your picks today, Boss!! (I'm movin' to Miami to play this stuff!!!)

SLXN.....................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

$2.25 +!68% it's in $1.94-)2.56 zone for now Best play in town so far this morning 

$2.15 + 60%

$1.84 rats incoming 

It reminds me of $ALUR smaller scale but similar float and price action. I think it triggers Algo Bot 🤖 buying it's not retail deciding most of these runs. $5 would be great I'm just hoping for $2-$3

Flying again AH 
5$